What is the equity of MorphoSys this year?
MorphoSys has equity of 49.05 M EUR this year.
MorphoSys Equity 2024
MorphoSys Equity
49.05 M EUR
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's equity was 49.05 M EUR, a -68.84% increase from the 157.41 M EUR equity in the previous year.
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing MorphoSys's Equity
MorphoSys's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding MorphoSys's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating MorphoSys's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
MorphoSys's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in MorphoSys’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about MorphoSys stock
What was the equity of MorphoSys compared to the previous year?
The equity of MorphoSys has increased/decreased by -68.84% decreased compared to the previous year.
What impact does a high equity have on investors of MorphoSys?
A high equity is advantageous for investors of MorphoSys as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of MorphoSys?
A low equity can be a risk for investors of MorphoSys, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of MorphoSys affect the company?
An increase in equity of MorphoSys can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of MorphoSys affect the company?
A reduction in equity of MorphoSys can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of MorphoSys?
Some factors that can affect the equity of MorphoSys include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of MorphoSys so important for investors?
The equity of MorphoSys is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can MorphoSys take to change the equity?
To change equity, MorphoSys can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 12/20/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 12/20/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
